Expanded Access to Rovalpituzumab Tesirine
Clinical trial NCT03503890 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03503890
- Sponsor
- AbbVie
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.